ANNOVIS BIO INC's ticker is ANVS and the CUSIP is 03615A108. A total of 25 filers reported holding ANNOVIS BIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,609 | -32.6% | 1,434 | +1.6% | 0.00% | – |
| Q2 2023 | $20,177 | -23.0% | 1,412 | -17.0% | 0.00% | – |
| Q1 2023 | $26,212 | -93.4% | 1,701 | -94.3% | 0.00% | – |
| Q4 2022 | $398,280 | -29.6% | 29,656 | -28.2% | 0.00% | – |
| Q3 2022 | $566,000 | -11.0% | 41,287 | -26.5% | 0.00% | – |
| Q2 2022 | $636,000 | -56.7% | 56,138 | -49.0% | 0.00% | – |
| Q1 2022 | $1,469,000 | -46.1% | 110,058 | -29.0% | 0.00% | – |
| Q4 2021 | $2,724,000 | +126.1% | 154,981 | +308.2% | 0.00% | – |
| Q3 2021 | $1,205,000 | -53.2% | 37,966 | +26.3% | 0.00% | – |
| Q2 2021 | $2,574,000 | +2283.3% | 30,070 | +110.5% | 0.00% | – |
| Q4 2020 | $108,000 | +56.5% | 14,286 | 0.0% | 0.00% | – |
| Q3 2020 | $69,000 | – | 14,286 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 463,797 | $3,497,000 | 1.42% |
| Worth Venture Partners, LLC | 119,538 | $901,000 | 0.71% |
| Lokken Investment Group LLC | 32,211 | $243,000 | 0.22% |
| Sterling Investment Advisors, Ltd. | 50,588 | $381,000 | 0.13% |
| Modera Wealth Management, LLC | 43,846 | $331,000 | 0.03% |
| Cannell & Co. | 10,000 | $75,000 | 0.00% |
| Sowell Financial Services LLC | 1,529 | $12,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 14,286 | $108,000 | 0.00% |
| BROWN ADVISORY INC | 14,942 | $113,000 | 0.00% |